CN Patent

CN119546302A — 用于治疗细菌性前列腺炎的吉泊达星

Assigned to GlaxoSmithKline Intellectual Property Development Ltd · Expires 2025-02-28 · 1y expired

What this patent protects

本发明涉及治疗细菌性前列腺炎的方法，其包括向有需要的人施用吉泊达星或其药学上可接受的盐。

USPTO Abstract

本发明涉及治疗细菌性前列腺炎的方法，其包括向有需要的人施用吉泊达星或其药学上可接受的盐。

Drugs covered by this patent

Patent Metadata

Patent number: CN119546302A
Jurisdiction: CN
Classification: —
Expires: 2025-02-28
Drug substance claim: No
Drug product claim: No
Assignee: GlaxoSmithKline Intellectual Property Development Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.